While cognitively normal subjects did not show an age-dependent change in CLDN-5 (Figure 4A), plasma CLDN-5 levels were higher in younger than in older patients in both the MCI (p < 0.001) and AD (p < 0.01) groups (Figure 4B,C). Here, CLDN5 is linked to Alzheimer disease.